Skip to content
LexBuild

Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC)

---
identifier: "/us/fr/E9-21920"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC)"
title_number: 0
title_name: "Federal Register"
section_number: "E9-21920"
section_name: "Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC)"
positive_law: false
currency: "2009-09-10"
last_updated: "2009-09-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-21920"
document_type: "notice"
publication_date: "2009-09-10"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "74 FR 46610"
fr_volume: 74
---

#  Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention announces the following Subcommittee meeting:

*Time and Date:* 10:30 a.m.-12:30 p.m., September 24, 2009.

*Place:* The teleconference call will originate at the Centers for Disease Control and Prevention in Atlanta, Georgia. Please see “Supplementary Information” for details on accessing the teleconference.

*Status:* Open to the public, teleconference access limited only by availability of telephone ports. The public is welcome to participate during the public comment period which is tentatively scheduled from 12:15 p.m.-12:25 p.m.

*Purpose:* The Ethics Subcommittee will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners.

*Matters To Be Discussed:* The teleconference agenda will include ethical guidance for ventilator distribution during a pandemic, update on CDC's public health ethics activities, and follow-up on outstanding activities/reports.

Agenda items are subject to change as priorities dictate.

*Supplementary Information:* This conference call is scheduled to begin at 10:30 a.m. To participate in the teleconference, please dial 1/866/919-3560 and enter conference code 4168828. You will then be automatically entered into the call.

*Contact Person for More Information:* Drue Barrett, PhD, Designated Federal Officer, Ethics Subcommittee, CDC, 1600 Clifton Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404/639-4690. E-mail: *[email protected]* .

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: September 1, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.